Golden State Medical Supply is recalling 19 lots of ranitidine capsules, following a manufacturer's recall by East Windsor, N.J.-based Novitium Pharma.
GSMS said its 150 mg and 300 mg ranitidine capsules potentially contain levels of a carcinogen, N-Nitrosodimethylamine, above levels deemed acceptable by the FDA.
It hasn't received reports of adverse events related to the recall.
The affected lots were primarily sold to AmerisourceBergen, McKesson and Tricare Mail Order Pharmacies. Distributors are advised to stop distribution, quarantine all remaining products and return them to GSMS.
Patients are advised to consult with their physician about an alternative treatment before stopping use of the ranitidine capsules.
Read the full news release here.